Guardian Pharmacy Services, Inc.
GRDNNYSECIK 1802255Consumer staplesFiscal year ends Dec 31
Reports and events: 43 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2817:02 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-405492 |
| 2026-09-1016:05 ET | 8-K | 8.01 Other events | 0001193125-26-387858 |
| 2026-08-0616:17 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-338074 |
| 2026-08-0616:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-338032 |
| 2026-06-2216:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-277596 |
| 2026-05-2816:11 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-245235 |
| 2026-05-0716:12 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-211924 |
| 2026-05-0616:16 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-209021 |
| 2026-05-0616:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-208989 |
| 2026-03-2607:18 ET | DEF 14A | Proxy statementPeriod 2026-05-05 | 0001193125-26-125070 |
| 2026-03-2418:17 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-122330 |
| 2026-03-2316:19 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-119772 |
| 2026-03-1116:15 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-102172 |
| 2026-03-1116:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-102153 |
| 2026-01-1316:41 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-011826 |
| 2025-11-1016:17 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-274298 |
| 2025-11-1016:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-274250 |
| 2025-10-1416:51 ET | 8-K | 8.01 Other events | 0001193125-25-239120 |
| 2025-09-1806:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-206771 |
| 2025-08-1116:26 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001193125-25-177969 |
| 2025-08-1116:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-177963 |
| 2025-07-2916:54 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-099705 |
| 2025-06-1809:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-142451 |
| 2025-05-2916:05 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-078935 |
| 2025-05-2016:09 ET | S-1 | Registration statement | 0001193125-25-123149 |
| 2025-05-2016:06 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-123145 |
| 2025-05-1216:25 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-117815 |
| 2025-05-1216:20 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001193125-25-117801 |
| 2025-05-1216:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-117795 |
| 2025-03-2816:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-067044 |
| 2025-03-2807:20 ET | DEF 14A | Proxy statementPeriod 2025-05-09 | 0001193125-25-066235 |
| 2025-03-2616:15 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001193125-25-064082 |
| 2025-03-2616:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-064079 |
| 2025-03-0306:16 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-043339 |
| 2025-02-1116:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-024341 |
| 2025-02-0317:00 ET | SCHEDULE 13D | Ownership report, active investor | 0000950170-25-012420 |
| 2024-12-2016:06 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-283106 |
| 2024-11-1217:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001193125-24-256069 |
| 2024-11-1216:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-255981 |
| 2024-09-3016:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-228997 |
| 2024-09-1608:22 ET | S-1/A | Registration statement, amended | 0001193125-24-219239 |
| 2024-08-2217:17 ET | S-1/A | Registration statement, amended | 0001193125-24-205420 |
| 2023-10-0317:03 ET | S-1 | Registration statement | 0001193125-23-250013 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.